SimBioSys Appoints Stacey Stevens as President and CEO
Stevens brings decades of healthcare leadership and innovation to TechBio company at the forefront of advancing digital precision medicine to...
Healthcare
Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
BOSTON, Jan. 9, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity,...
RXNT Named by Black Book as Standout Leader; EHR Software Receives #1 Rankings for Ambulatory Care Physicians
Healthcare technology pioneer RXNT has been recognized by Black Book as one of six standout EHR software leaders for ambulatory...
Deerfield Group Enhances Strategic Marketing, Communications Services for Biopharma, Health Tech Companies on West Coast
Marites Coulter, Senior Vice President, Client Services, to spearhead growth initiative in region CONSHOHOCKEN, Pa., Jan. 9, 2025 /PRNewswire/ --...
Spurred by megadeals, global healthcare private equity deal value soared to $115 billion in 2024, the second-highest total on record
Despite high borrowing costs and extended hold times in 2024, dealmaking roared ahead for healthcare private equity with a heavy...
Generate:Biomedicines Provides Update on its Platform and Pipeline Powered by AI at the 43rd Annual J.P. Morgan Healthcare Conference
SOMERVILLE, Mass., Jan. 9, 2025 /PRNewswire/ -- Generate:Biomedicines ("Generate") today announced that Mike Nally, Chief Executive Officer, will provide an...
Quest International Achieves ANSI/ESD Certification for German Facility, Strengthening International Depot Repair Services and Capabilities
The Certification Joins Quest's 4 Existing ISO Registrations to Form the Industry's Most Complete Quality Management System IRVINE, CALIFORNIA /...
Hemostemix and CytoImmune Amend Manufacturing Agreement to Accelerate Global Scale-Up
Calgary, Alberta--(Newsfile Corp. - January 9, 2025) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) is pleased to announce...
UniDoc – Company Recognizes Initial Revenue on Delivery of AI-Equipped H3 Health Cubes
Three customers take delivery at year endVANCOUVER, BC / ACCESSWIRE / January 9, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc,"...
Avel eCare Announces Acquisition of Amwell Psychiatric Care to Expand Telemedicine Services
SIOUX FALLS, SD / ACCESSWIRE / January 9, 2025 / Avel eCare, the nation's leading telemedicine provider of clinician-to-clinician services,...
CliniOps Announces Strategic Partnership With Indegene to Accelerate Clinical Trials
Offers an end-to-end platform for patient recruitment, data management, Biostatistics and regulatory submission FREMONT, CALIFORNIA / ACCESSWIRE / January 9,...
Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco
LOS GATOS, CA / ACCESSWIRE / January 9, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company...
Nanomerics Reports Complete Dosing of the Last Volunteer in the OC134 SUNLIGHT Trial
LONDON, GB / ACCESSWIRE / January 9, 2025 / Nanomerics Ltd., a private speciality pharmaceutical company today announced that it...
AI/ML Innovations Inc. Welcomes Industry Veterans to Board of Directors
Mark Orsmond, a highly respected business professional in Canadian Healthcare, Appointed Executive ChairMichael Nemirow Joins as Director, Bringing Decades of...
BioLizard Welcomes Arjan van Manen as Commercial Director and Announces Presence at JPM Week in San Francisco
Arjan van Manen joins BioLizard as Commercial Director, bringing over 20 years of commercial leadership experience in life sciencesMeet BioLizard’s...
Lyell to Highlight Vision for its Next-Generation CAR T-Cell Therapy Pipeline at 43rd Annual JP Morgan Healthcare Conference
Accelerating IMPT-314 in large B-cell lymphoma; remain on track to initiate pivotal trial in the 3rd line+ setting in 2025...
FYR Appoints Chris Howlett to its Board of Directors
Appointment adds business, market and partner development expertise to FYR board Addition highlights FYR’s evolution into partner of choice for...
Alkeus Pharmaceuticals Announces New Positive Interim TEASE-3 Study Results Showing Gildeuretinol Prevented Disease Progression in Early-Stage Stargardt Patients
Two additional TEASE-3 participants who recently completed 24 months of therapy showed no disease progression, consistent with prior results. A...
Hydreight Technologies Provides Shareholder Update on 2024 Milestones and 2025 Vision
VANCOUVER, British Columbia and LAS VEGAS, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV:...
Amwell® divests virtual psychiatric care business to Avel eCare in all-cash transaction
Divestment of Amwell Psychiatric Care intended to focus product portfolio on key growth initiatives Company reiterates guidance for 2024 BOSTON,...